rs200781822
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001038603.3(MARVELD2):c.1183-1G>A variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.00000889 in 1,461,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_001038603.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251408Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135890
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461792Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727204
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 49 Pathogenic:3
- -
MARVELD2 (also known as TRIC, encoding tricellulin) c.1183-1G>A (p.?) alters a splice-site that has been reported to result in the deletion of the first 17 nucleotides of TRIC exon 4, leading to a frameshift and premature termination of protein translation (PMID: 17186462). This variant segregated with autosomal recessive nonsyndromic hearing loss in one family (PMID: 17186462). -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at